Skip to main content
. Author manuscript; available in PMC: 2013 Dec 1.
Published in final edited form as: Arch Neurol. 2012 Dec;69(12):1621–1627. doi: 10.1001/archneurol.2012.1527

Table 1.

Descriptive statistics at baseline evaluation for incident dementia cases, participants who remained non-demented, and total sample

Remained non- demented (n=457) Incident dementia (n=46) Total sample (n=503) Statistics
Age at baseline (mean ± SD years) 79.41±5.12 82.15±5.55 79.66±5.20 t(501)=3.434, p=0.001
Education (mean ± SD years) 11.12±4.86 7.70±5.01 10.58±4.37 t(499)=4.537, p<0.001
Race/Ethnicity % White/other 30.2 21.7 29.6 χ2(2)=7.083, p=0.029
% African American 33.2 21.7 32.1
% Hispanic 36.5 56.5 38.3
APOE ε4 frequency 24.4 22.7 24.3 χ2(1)=0.062, p=0.803
Vascular risk factors % Diabetes mellitus 21.0 23.9 21.3 χ2(1)=0.211, p=0.646
% Hypertension 69.1 65.2 68.8 χ2(1)=0.301, p=0.584
% Heart disease 22.5 17.4 22.1 χ2(1)=0.644, p=0.422
% Stroke 9.8 15.2 10.3 χ2(1)=1.300, p=0.254
Vascular history score (median) 1 1 1 Mann-Whitney U = 10242.50, p=0.761
Time between MRI scan and baseline evaluation (mean ± SD months) 0.96±5.27 1.61±7.05 0.79±6.25 t(499)=0.766, p=0.444
Time between MRI scan and follow-up visit (mean ± SD months) 40.18±9.68 41.63±10.69 40.28±9.77 t(474)=0.911, p=0.363
Regional WMH volume (mean ± SD cm3) Frontal 1.69±3.19 2.04±2.84 1.70±3.16 Diagnostic Group: F(1,441)=0.258, p=0.612), Group by Region: F(3,1323)=0.534, p=0.659)
Temporal 0.12±0.28 0.13±0.23 0.12±0.27
Parietal 1.24±2.48 1.77±2.55 1.29±2.49
Occipital 0.16±0.38 0.13±0.17 0.15±0.37
Relative hippocampus volume 0.29±0.06 0.28±0.07 0.29±0.06 F(1,435)=0.339, p=0.561